Your browser does not support JavaScript!

Appareils et matériels

789 entreprises et organismes intervenants dans le domaine 'Appareils et matériels', classés par activité.

Rejoignez la communauté
Trouvez du matériel
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Hier à 11:52
Merck buzzes Dragonfly for 2nd immunotherapy candidate in $700M pact month after Bristol Myers' 6th opt-in
Merck buzzes Dragonfly for 2nd immunotherapy candidate in $700M pact month after Bristol Myers' 6th opt-in klahucik Tue, 11/23/2021 - 14:00 ...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Il y a 2 jours
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet ntaylor Wed, 11/24/2021 - 08:23 ...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
Pfizer doles out $15M to Cardiff to advance a challenger to Amgen's KRAS winner Lumakras
Pfizer doles out $15M to Cardiff to advance a challenger to Amgen's KRAS winner Lumakras klahucik Thu, 11/18/2021 - 09:28 ...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de Labiotech.eu
Il y a 1 semaine
Big Pharma Strikes Megadeals In Targeted Protein Degradation
With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed between biotech startups and big pharma in this upcoming area. Novartis, Pfizer,...
www.labiotech.eu
PFIZER
est cité dans une actualité de FierceBiotech
Il y a 3 semaines
Pfizer sells midphase inflammatory drugs to mystery startup, exiting race against Bristol Myers
Pfizer sells midphase inflammatory drugs to mystery startup, exiting race against Bristol Myers ntaylor Tue, 11/02/2021 - 08:29 ...
www.fiercebiotech.com
Une question a été posée - Il y a 3 semaines
Image Turbula
Une actualité de FierceBiotech a été ajouté(e)
Le 27/10/2021
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors 
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors ntaylor Tue, 10/26/2021 - 08:00 ...
www.fiercebiotech.com
2 entreprise(s)
Une actualité de FierceBiotech a été ajouté(e)
Le 27/10/2021
Eli Lilly, Bayer, Merck join Mozart's chorus to the tune of $55M, as it launches into allegro phase
Eli Lilly, Bayer, Merck join Mozart's chorus to the tune of $55M, as it launches into allegro phase klahucik Tue, 10/26/2021 - 09:12 ...
www.fiercebiotech.com
2 entreprise(s)
SANOFI AVENTIS
est cité dans une actualité de FierceBiotech
Le 25/10/2021
With Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more
With Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more apark Fri, 10/22/2021 - 14:00 ...
www.fiercebiotech.com
SANOFI AVENTIS
est cité dans une actualité de FierceBiotech
Le 15/10/2021
Sanofi tries to quiet naysayers with follow-up data on MS drug at heart of $3.7B Principia buyout
Sanofi tries to quiet naysayers with follow-up data on MS drug at heart of $3.7B Principia buyout aarmstrong Thu, 10/14/2021 - 09:30 ...
www.fiercebiotech.com
Charger plus d'actualités